Diplomat calls US’ allegations about isolation of Russia in UN 'strange'Russian Politics & Diplomacy April 28, 20:58
Experts say Russian hackers strongly demonized in USRussian Politics & Diplomacy April 28, 20:35
Ferrari drivers clock best time in Practice Two of Russia F1 GP in SochiSport April 28, 19:54
Red Bull’s advisor Marko says Kvyat to possibly remain with Toro Rosso next yearSport April 28, 19:16
Pope Francis blesses pregnant TASS correspondent en route to EgyptWorld April 28, 18:55
Russian diplomat says use of military force against North Korean unacceptable, dangerousRussian Politics & Diplomacy April 28, 18:45
UN chief calls for lowering risk of miscalculation concerning North Korea issueWorld April 28, 18:15
Moscow deeply regrets Montenegro’s decision to join NATORussian Politics & Diplomacy April 28, 18:07
Maria Sharapova reaches Porsche Tennis Grand Prix semifinalsSport April 28, 17:50
RIO DE JANEIRO, August 17./TASS/. The World Boxing Council (WBC) has disqualified Russian boxer Alexander Povetkin indefinitely after he tested positive for banned substance meldonium, its press service said.
Povetkin was under an investigation on doping abuse accusations. He is suspended from competitions as well as stripped of the title of mandatory challenger.
Promoter Andrei Ryabinsky of World of Boxing is ready to defend the interests of Povetkin and sue the WBC.
"We are filing a lawsuit against WBC," Ryabinsky told TASS.
WBC Heavyweight Champion Deontay Wilder of the United States (W36-L0, 35 KOs) was scheduled to hold his mandatory title bout against Povetkin (30-1, 22 KOs) on May 21 in Moscow. However Russian boxer’s doping Sample A had tested positive for meldonium shortly before the fight and the bout was suspended indefinitely. His Sample B also tested positive for the same substance.
Povetkin has been suspended from boxing as well as stripped of the title of mandatory challenger. Wilder now has the right to choose the contender he thinks fit.
WBC may revise its decision if the World Anti-Doping Agency (WADA) issues new recommendations on meldonium or any other major information emerges to this respect.